THE KAMEN BRAIN TUMOR FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

DR MAZEN KAMEN MD

Phone

2124275800

Tax Period

2023-01-01 to 2023-12-31

THE KAMEN BRAIN TUMOR FOUNDATION, founded in 2016, is a small nonprofit in the Diseases & Disorders sector that reported $557K in total revenue in fiscal year 2023. Revenue surged 213% from the prior year, signaling strong growth momentum.

Mission

THE FOUNDATION WAS ORGANIZED TO CONSIDER VARIOUS MEDICAL RESEARCH PROJECTS TO TREAT PEDIATRIC BRAIN TUMORS AND TO FUND THE MOST PROMISING PROJECTS.

Program Service Accomplishments

Program 1

Expenses: $301,000

GRANT TO WEILL MEDICAL COLLEGE, NEW YORK, NY AND MEMORIAL SLOAN KETTERING CANCER CENTER NEW YORK, NY, AND GIVE BACK FOUNDATION NEW YORK, NY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $556,901

Program Service Revenue $0

Investment Income $7

Other Revenue $0

TOTAL REVENUE $556,908

Expense Breakdown

Grants Paid $301,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $590,702

Other Expenses $289,202

TOTAL EXPENSES $590,702

Year-over-Year Comparison

	2023	2022	Change
Revenue	$556,908	$178,136	+2.1%
Expenses	$590,702	$181,575	+2.3%
Net Income	$-33,794	$-3,439	+8.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHARLES GOODFELLOW	DIRECTOR	N/A	Director	$0	$0	$0
EDWARD GREGORY	DIRECTOR	N/A	Director	$0	$0	$0
RANDA HAFFAR	DIRECTOR	N/A	Director	$0	$0	$0
JILL KARR KAMEN	DIRECTOR	N/A	Director	$0	$0	$0
SCOTT KAMEN	DIRECTOR	N/A	Director	$0	$0	$0
IRA DUNKEL MD	DIRECTOR	N/A	Director	$0	$0	$0
DR MAZEN KAMEN MD	PRESIDENT	N/A	Officer	$0	$0	$0
STUART A SMITH	SECRETARY	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$556,908	$590,702	$157,015	$-33,794
2022	$178,136	$181,575	$190,809	$-3,439
2021	$33,513	$210,166	$194,248	$-176,653
2020	$179,626	$146,780	$399,561	$32,846